Hendrik Peter Scholl sold $1.4M of Belite Bio (BLTE)

Executed Jun 18, disclosed Jun 22, 4 days later.

Value, as filed

$1.4M

9,808 sh across 3 lots

Executed

Jun 18

the trade date, as filed

Disclosed

Jun 22

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

HS Hendrik Peter Scholl Chief Medical Officer profile →

Hendrik Peter Scholl (Chief Medical Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Belite Bio, Inc (BLTE). The largest single filing was $1.4M of BLTE (9,808 sh across 3 lots, as filed), executed Jun 18.

The name

BLTE Belite Bio, Inc BLTE · Healthcare · 7 filings in 24 months ticker →

Healthcare · Belite Bio, Inc, a clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Hendrik Peter Scholl in BLTE

BLTESALE Belite Bio, Inc $1.3M
8,910 sh across 5 lots
Exec Jun 16
Filed Jun 17 · 5:30 PM ET